Skip to content

GREENWICH LIFESCIENCES, INC.

GLSI

CIK 0001799788

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$17.09M
−421.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.20
−429.6% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$6.18M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
14.68M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings